Table 1.

Incidence of Common Cancers as First Primary Cancer and Second Primary Cancer, and Respective Relative Risk (RR) in Men

First Primary Cancer				Second Primary Cancer After Invasive SCC
Cancer	Number of Cases	Standardized Rate 1/100,000	Rank1	Number of Cases	Standardized Rate 2/100,000	Rank2	RR	95% CI
Prostate	185,081	95.2	1	1483	110.4	1	1.16	1.10	1.22
Colorectum	60,037	32.2	2	545	42.5	3	1.32	1.21	1.44
Lung	41,165	23.5	3	372	40.9	4	1.74	1.57	1.93
Bladder	35,818	18.9	4	374	26.5	7	1.40	1.27	1.55
Melanoma	22,812	14.7	5	355	47.5	2	3.23	2.91	3.60
Leukemia	17,318	11.3	6	180	21.7	8	1.92	1.66	2.23
NHL	18,414	11.3	7	237	26.8	6	2.37	2.08	2.70
Nervous system	14,199	11.1	8	45	15.0	9	1.35	1.01	1.81
Kidney	13,922	8.7	9	98	13.3	10	1.53	1.26	1.87
Stomach	13,800	7.3	10	152	12.4	11	1.70	1.44	1.99
UAT	11,371	7.2	11	195	27.3	5	3.79	3.29	4.38
Liver	10,990	6.3	12	82	8.8	12	1.39	1.12	1.72
Myeloma	7202	4.0	13	52	4.6	14	1.15	0.88	1.51
Endocrine	5558	3.9	14	16	3.9	15	0.99	0.60	1.62
Connective tissue	3564	2.4	15	46	6.3	13	2.64	1.97	3.54
Hodgkin lymphoma	2399	2.0	16	8	3.8	16	1.91	0.95	3.85
Thyroid	2213	1.6	17	10	2.3	18	1.45	0.78	2.71
Small intestine	2423	1.5	18	21	2.5	17	1.65	1.07	2.54
Male genital	1835	1.1	19	22	2.1	19	1.94	1.27	2.96
Breast	803	0.5	20	14	1.3	20	2.62	1.54	4.47
All*	515,982	256.0	–	4662	376.3	–	1.47	1.43	1.51

Notes: *Skin cancer is removed from all cancers; some rare cancers, not listed in Table 1 are included. Bolding shows RRs>2.00.

Abbreviations: SCC, squamous cell carcinoma; NHL, non-Hodgkin lymphoma; UAT, upper aerodigestive tract.